Distinct Clinical Associations of Blood Tau Biomarkers and Neurofilament Light in Amyotrophic Lateral Sclerosis
B. Bertrán Recasens, Paula Ortiz‐Romero, Ferran Lugo-Hernández, Sergio Vidal Notari et autres
0 citationsmedRxiv
Paula Ortiz‐Romero
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
52Publications signalées
979Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsWilliams Syndrome ResearchNuclear Receptors and SignalingIntracerebral and Subarachnoid Hemorrhage Research
Publications récentes
Shorter leukocyte telomere length is associated with distinct CSF biomarker dynamics across early AD stages in at‐risk individuals
Blanca Rodríguez‐Fernández, Armand González Escalante, Patricia Genius, Tavia E. Evans et autres
0 citationsAlzheimer s & Dementia
Predicting cognitive trajectories in asymptomatic individuals at‐risk of AD: insights from a multi‐platform plasma proteomics study
Federica Anastasi, Armand González Escalante, Pol Segura‐Retana, Paula Ortiz‐Romero et autres
0 citationsAlzheimer s & Dementia
Synergistic Effects of Plasma p ‐tau217 and GFAP on Neurodegeneration and Cognitive Decline in Cognitively Unimpaired Individuals
Raffaele Cacciaglia, Armand González Escalante, Paula Ortiz‐Romero, Oriol Grau‐Rivera et autres
0 citationsAlzheimer s & Dementia
Exploring Associations Between Longitudinal [ 18 F]RO‐948 Tau PET, Baseline Fluid tau Biomarkers, and memory in the Early Alzheimer's Disease continuum
Mahnaz Shekari, Armand González Escalante, David López‐Martos, Marta Milà‐Alomà et autres
0 citationsAlzheimer s & Dementia
Plasma biomarkers predict long‐term longitudinal cognitive decline in individuals at‐risk for Alzheimer's disease: differences across demographic groups
Armand González Escalante, Paula Ortiz‐Romero, Javier Torres‐Torronteras, Esther Jiménez‐Moyano et autres
0 citationsAlzheimer s & Dementia
Detecting Amyloid–β Pathology in Subjective Cognitive Decline using novel CSF and plasma biomarkers
José Contador, Federico Emanuele Pozzi, Gonzalo Sánchez‐Benavides, Ana Fernández‐Arcos et autres
0 citationsAlzheimer s & Dementia
Early Disclosure of Blood‐Based Biomarkers Optimizes Alzheimer's Disease Management and Treatment Initiation: the PLASMAR study
Isabel Estragués‐Gázquez, José Contador, Leidy Dayana Martinez, Aida Fernández‐Lebrero et autres
0 citationsAlzheimer s & Dementia
Sex‐specific associations between age‐related blood proteins, cognition, and Alzheimer's biomarkers
Luis Felipe Hernández‐Villamizar, Luisa Sophie Braun-Wohlfahrt, Greta Garcia‐Escobar, Marina De Diego‐Osaba et autres
0 citationsAlzheimer s & Dementia
Impact of fasting status and storage time on plasma Amyloid-β 42 and 40, p-tau181, p-tau231, GFAP and NfL measurements
Helena Blasco‐Forniés, Javier Torres-Torronteras, Armand González‐Escalante, Federica Anastasi et autres
0 citationsResearch Square
Associations of 18 F-RO-948 Tau PET with Fluid AD Biomarkers, Centiloid, and Cognition in the Early AD Continuum
Mahnaz Shekari, Armand González Escalante, Marta Milà‐Alomà, Carles Falcón et autres
0 citationsmedRxiv
Preclinical evidence for the role of BKCa channels as a novel therapeutic target for Williams-Beuren syndrome
Celeste Ferraguto, Marion Piquemal-Lagoueillat, Victoria Campuzano, Luigi Bellocchio et autres
0 citationsHAL (Le Centre pour la Communication Scientifique Directe)
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.